Synaptogenix Inc (SNPX)

[kc44]

Here's my take and after I write it down here it's certainly A thought that should be considered.

Dementia and AD are the biggest drains on healthcare currently. So with that said every large pharmaceutical company is certainly aware of every different phase of research all companies are in. It is their business to know these things and I don't think anybody can deny that fact.

Of course I can't say for certain but following biotech and pharmaceutical's for at least the past 10 years it is obvious that NTRP has been approached by big Pharma as to what they will do if they find themselves with their hands around a drug that can treat these diseases on any level.

My guess along with data crunching their also considering different offers if the data is good or even has potential to move forward. The potential for large Pharma is just too great not to be in talks.

My guess is they've already had offers on a sliding scale depending on the study outcome.